FDA — authorised 19 December 1986
- Application: ANDA062690
- Marketing authorisation holder: GLAXOSMITHKLINE
- Local brand name: TICAR
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Ticarcillin in United States
FDA authorised Ticarcillin on 19 December 1986
Marketing authorisations
FDA
- Status: approved
Ticarcillin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Ticarcillin approved in United States?
Yes. FDA authorised it on 19 December 1986; FDA has authorised it.
Who is the marketing authorisation holder for Ticarcillin in United States?
GLAXOSMITHKLINE holds the US marketing authorisation.